Good Steward Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Good Steward Wealth Advisors's BMY Position: Q1 2026 in Review
Good Steward Wealth Advisors reduced its Bristol-Myers Squibb (BMY) stake by 1.8% in Q1 2026, selling an estimated $4.49K and leaving 4,219 shares worth $256K. The position accounts for 0.16% of the portfolio, ranked #56.
Good Steward Wealth Advisors first reported a position in BMY in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.15M in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Good Steward Wealth Advisors held 4,219 shares of Bristol-Myers Squibb worth $256K as of Q1 2026.
- Good Steward Wealth Advisors sold 77 Bristol-Myers Squibb shares in Q1 2026, an estimated $4.49K.
- Bristol-Myers Squibb made up 0.16% of Good Steward Wealth Advisors's portfolio in Q1 2026, its #56 holding.
- Good Steward Wealth Advisors first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 5 quarters since.
- Good Steward Wealth Advisors's Bristol-Myers Squibb position peaked at $1.15M in Q1 2025.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Good Steward Wealth Advisors's 13F filing for Q1 2026, filed 4 May 2026.